Global Health Limited (IN:MEDANTA)
:MEDANTA
MEDANTA Stock Chart & Stats
₹1216.65
₹16.70(1.57%)
At close: 4:00 PM EST
₹1216.65
₹16.70(1.57%)
Day’s Range― - ―
52-Week Range₹955.20 - ₹1,455.85
Previous CloseN/A
Volume335.07K
Average Volume (3M)17.50K
Market Cap
₹284.55B
Enterprise Value₹286.44B
Total Cash (Recent Filing)₹12.55B
Total Debt (Recent Filing)₹9.45B
Price to Earnings (P/E)83.8
Beta0.56
Next Earnings
May 15, 2026EPS Estimate
4.5Next Dividend Ex-DateN/A
Dividend Yield0.04%
Share Statistics
EPS (TTM)4.60
Shares Outstanding268,790,370
10 Day Avg. Volume39,597
30 Day Avg. Volume17,497
Financial Highlights & Ratios
PEG Ratio101.90
Price to Book (P/B)9.77
Price to Sales (P/S)9.09
P/FCF Ratio308.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,440.00Price Target Upside18.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)25.88
Revenue Forecast (FY)₹50.12B
Bulls Say, Bears Say
Bulls Say
Revenue Growth TrendConsistent top-line expansion (12.74% YoY in 2025) indicates durable demand for tertiary/quaternary care and improving case mix. Sustained revenue growth supports scale advantages, better fixed-cost absorption, and long-run ability to invest in specialty services and capacity.
Conservative Leverage And Strong ROEA low debt-to-equity ratio and high equity ratio signal a conservative capital structure that reduces refinancing risk and interest burden. Combined with 14% ROE, this balance sheet strength gives flexibility to fund expansion, withstand demand shocks, and support long-term investments.
Operating Cash GenerationOperating cash flows that consistently cover net income demonstrate strong cash conversion from hospital operations. Reliable cash generation supports working capital, debt servicing and reinvestment in high-acuity facilities, underpinning sustainable operations over multiple years.
Bears Say
Free Cash Flow VolatilityA marked drop in free cash flow in 2025 shows sensitivity to capex and timing, which can constrain discretionary spending, dividend policy, or organic expansion. Persistent FCF volatility increases reliance on external financing and raises execution risk for long-term projects.
High Capital IntensityHospital operations require substantial, ongoing capital expenditures for equipment, ICUs and theatres. This structural capital intensity increases funding needs and makes margins and free cash flow more sensitive to utilization cycles and costly upgrades over time.
Limited Corporate Disclosure/eventsThe absence of regular earnings call details or notable corporate events reduces transparency into strategy, capital allocation and clinical capacity plans. Limited investor communication can hinder stakeholder oversight and raise uncertainty about long-term execution priorities.
Global Health Limited News
MEDANTA FAQ
What was Global Health Limited’s price range in the past 12 months?
Global Health Limited lowest stock price was ₹955.20 and its highest was ₹1455.85 in the past 12 months.
What is Global Health Limited’s market cap?
Global Health Limited’s market cap is ₹284.55B.
When is Global Health Limited’s upcoming earnings report date?
Global Health Limited’s upcoming earnings report date is May 15, 2026 which is in 35 days.
How were Global Health Limited’s earnings last quarter?
Global Health Limited released its earnings results on Feb 04, 2026. The company reported ₹4.6 earnings per share for the quarter, missing the consensus estimate of ₹5.31 by -₹0.71.
Is Global Health Limited overvalued?
According to Wall Street analysts Global Health Limited’s price is currently Undervalued.
Does Global Health Limited pay dividends?
Global Health Limited pays a Notavailable dividend of ₹0.5 which represents an annual dividend yield of 0.04%. See more information on Global Health Limited dividends here
What is Global Health Limited’s EPS estimate?
Global Health Limited’s EPS estimate is 4.5.
How many shares outstanding does Global Health Limited have?
Global Health Limited has 268,790,370 shares outstanding.
What happened to Global Health Limited’s price movement after its last earnings report?
Global Health Limited reported an EPS of ₹4.6 in its last earnings report, missing expectations of ₹5.31. Following the earnings report the stock price went up 0.669%.
Which hedge fund is a major shareholder of Global Health Limited?
Currently, no hedge funds are holding shares in IN:MEDANTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Global Health Limited
Global Health Limited, a multi-specialty tertiary care provider, offers healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. It operates a network of four hospitals in Gurugram, Indore, Ranchi, and Lucknow under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurgaon, India.
MEDANTA Stock 12 Month Forecast
Average Price Target
₹1,440.00
▲(18.36% Upside)
Technical Analysis
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Krishna Institute of Medical Sciences Limited
―
Metropolis Healthcare Ltd.
―
Narayana Hrudayalaya Ltd.
―